GGT was first proposed to play a role in tumor formation in the 1980s, when it was found to be overexpressed in pretumor liver foci of chemically treated rats, and the expression of GGT could provide a selective growth advantage to the cells within the foci at the stage of cancer promotion. This evidence concerns the gene GGTLC3 and cancer.